| INIFY LABORATORIES AB |
| Schweden |
| Gesundheit |
| SE0017486103 / A3DFA6 |
| WY60 (Frankfurt) |
| FRA:WY60, ETR:WY60, WY60:GR |
| - |
| https://www.inify.com/ |
|
Inify Laboratories AB is a prominent player in specialized laboratory services, leveraging cutting-edge technology to enhance diagnostic accuracy. The company focuses on providing pathology services with an emphasis on digital pathology solutions, wh..
>Volltext.. |
| 34.49 Mio. EUR |
| 28.94 Mio. EUR |
| 1.98 Mio. EUR |
| -5.78 Mio. EUR |
| -6.11 Mio. EUR |
| -0.09 EUR |
| - |
| 5.34 Mio. EUR |
| - |
| 1.9 |
| 74.61% |
| -37.07% |
| - |
| - |
| - |
| - |
| INIFY LABORATORIES, INIFY LABS |
| 08.04.26 |
|